Xi'an MicroPace MedTech key facts
as of Oct 2026- Developer and manufacturer of high-end medical devices based in Xi'an, China.
- Xi'an MicroPace MedTech is valued at approximately $44.4M as of Oct 2026 (last reported valuation).
- It has raised $12.4M; the latest was Later Stage VC ($5.5M) in Jan 2025.
- Notable investors include Qiming Venture Partners, Proxima Ventures (China), Xinke Capital, TigerYeah Capital.
- Status: Privately Held (backing).
Xi'an MicroPace MedTech's last reported valuation, Jan 2025. Nothing priced has surfaced since.
- ·Watch Xi'an MicroPace MedTech: the Monday email on marks, rounds and moves
Xi'an MicroPace MedTech funding rounds
No funding rounds for Xi'an MicroPace MedTech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Xi'an MicroPace MedTech
4Xi'an MicroPace MedTech valuation
Xi'an MicroPace MedTech's last reported valuation was $44.4 million in Jan 2025. No priced round, secondary trade or fund mark has surfaced since.
Xi'an MicroPace MedTech investors
4 investors are on record for Xi'an MicroPace MedTech, including Qiming Venture Partners, Proxima Ventures (China), Xinke Capital and TigerYeah Capital.
About Xi'an MicroPace MedTech
Developer and manufacturer of high-end medical devices based in Xi'an, China. The company develops and manufactures medical devices such as leadless pacemaker, neurostimulator, and defibrillator, committing to improving heart disease treatment.
- Sector
- Healthcare
- HQ
- Xi'an, China
- Founded
- 2018
- Employees
- 9
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.